A Physiologically Based Pharmacokinetic Model Characterizing Mechanism-based Inhibition of CYP1A2 for Predicting Theophylline/Antofloxacin Interaction in both Rats and Humans.
Summary of "A Physiologically Based Pharmacokinetic Model Characterizing Mechanism-based Inhibition of CYP1A2 for Predicting Theophylline/Antofloxacin Interaction in both Rats and Humans."
Clinical studies revealed that some fluoroquinolones may cause severe adverse effects when co-administered with substrates of CYP1A2. Our previous study showed antofloxacin (ATFX) mechanism-basely inhibited the metabolism of phenacetin in rats. In clinic, ATFX is likely to be administrated with theophylline (TP) which is mainly metabolized by CYP1A2. The aim of the present study was to investigate the possible mechanism of TP/ATFX interaction. In vitro studies showed that inhibitory effect of ATFX on formation of three TP metabolites depended on NADPH, pre-inhibition time and ATFX concentration, which characterized mechanism-based inhibition (MBI). In vivo studies demonstrated that single dose of ATFX (20 mg/kg) did not affect pharmacokinetic behavior of TP, but multidose of ATFX (20 mg/kg b.i.d. for 7.5 days) significantly increased AUC of TP, decreased the amount of three TP metabolites in urine and suppressed the hepatic microsomal activity. A physiologically based pharmacokinetic (PBPK) model characterizing MBI of three TP metabolites was developed for predicting TP/ATFX interaction in rats and further extrapolated to humans. The predicated results were in good agreement with observed data. All the results indicated that ATFX mechanism-basely inhibited the metabolism of TP and the PBPK model characterizing MBI may give good prediction of TP/ATFX interaction.
Affiliation
Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University.
Journal Details
This article was published in the following journal.
Name: Drug metabolism and pharmacokinetics
ISSN: 1880-0920
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21512260
- DOI: http://dx.doi.org/
Medical and Biotech [MESH] Definitions
Immunophenotyping
Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
Self Efficacy
Cognitive mechanism based on expectations or beliefs about one's ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. (APA, Thesaurus of Psychological Index Terms, 1994)
Beta-lactams
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Headache Disorders
Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Models, Statistical
Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc.
PubMed Articles
We conducted a pharmacokinetic (PK) study of mitoxantrone (Novantrone®), a clinically well-established anticancer agent, in mice and developed a mechanism-based PBPK (physiologically based pharmacoki...
Objective: To develop a pharmacokinetic model able to describe the nonlinear pharmacokinetics of paroxetine (PRX) and to predict the drug-drug interaction between PRX and metoprolol under various dosa...
We sought to develop a mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) model to characterize the effects of ginsenoside Rb1 (Rb1) and estradiol (E(2)) on neural 5-hydroxytryptamine (5-HT) conc...
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model has been developed for low, medium and high levels of soman intoxication in the rat, marmoset, guinea pig and pig. The prima...
PURPOSE: To characterize temporal exposure and elimination of 5 gold/dendrimer composite nanodevices (CNDs) (5 nm positive, negative, and neutral, 11 nm negative, 22 nm positive) in mice using a ph...
Clinical Trials
Post-Hospitalization Nursing Effectiveness (PHONE) Study
Based on success with telephone follow up for other groups of medically fragile infants, we designed an innovative model of post-hospital comprehensive and coordinated follow-up for infant...
Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
This study will determine if a version of the bipolar care model adapted for a nonresearch audience can improve patient health and correct use of the model in community-based mental health...
Telephone-based Care for OEF/OIF Veterans With PTSD
Objective: OEF/OIF (Operation Enduring Freedom and Operation Iraqi Freedom) veterans are presenting with high rates of PTSD. Translating Initiatives for Depression into Effective Solutio...
Implementing Telemedicine-Based Collaborative Care for MDD in Contract CBOCs
Small contract VA Community Based Outpatient Clinics present unique challenges to implementation of collaborative care because of their distinct organizational characteristics and lack of...
Utilization of HIV Clinical Services in Rural India
This community-based clinical trial based in two districts of rural Maharashtra, India compares utilization of an intervention model of "fully-decentralized," or rural primary clinic-based...
